ChemImage Issued Patent for Diagnosis of Kidney Cancer
Scientists at ChemImage Corporation are one step closer to making objective diagnoses of renal disease tissue a reality today with the issuance of patent number 7,755,757. This patent describes a Raman molecular imaging (RMI) system and method for distinguishing renal oncocytoma, a benign diagnosis, from chromophobe renal carcinoma, a malignant diagnosis.
View full press release